Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coagulation01:06

Coagulation

355
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
355
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

857
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
857
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

65
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
65
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

969
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
969
Colloidal precipitates01:09

Colloidal precipitates

725
The high insolubility of some precipitates can result in an unfavorable relative supersaturation. This can lead to colloidal particles with a large surface-to-mass ratio, where adsorption is promoted. For instance, in the precipitation of silver chloride, silver ions are adsorbed on the surface of the colloidal particles, forming a primary layer. This layer attracts ions of opposite charge (such as nitrate ions), forming a diffuse secondary layer of adsorbed ions. This electric double layer...
725

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural and functional benchmarking of monolayer- and bioreactor-generated hiPSC-derived cardiomyocytes.

APL bioengineering·2026
Same author

Extracorporeal Membrane Oxygenation in Pediatric Pulmonary Hypertension: A Single-Center Cohort to Inform Decision-Making.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

An RYR2-interacting fragment of MYBPC3 mitigates arrhythmia in human iPSC-CM and mouse models of CPVT.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Respiratory-physiology modeling of therapeutic hydrogen inhalation: defining the fraction of inspired hydrogen (FiH<sub>2</sub>) and flow-rate requirements.

Respiratory research·2026
Same author

Mitochondrial hyperoxidation contributes to warm ischemia-reperfusion injury in rat and pig livers.

Communications medicine·2026
Same author

The Effects of Vasoactive Medications on Mean Circulatory Filling Pressure, Venous Resistance, Systemic Vascular Resistance, Cardiac Index, and Oxygen Extraction After Pediatric Heart Transplant: Leveraging High-Fidelity Physiologic Data.

Children (Basel, Switzerland)·2026

Related Experiment Video

Updated: Aug 27, 2025

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
16:31

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Published on: June 6, 2011

25.0K

Low-Fouling Zwitterionic Polymeric Colloids as Resuscitation Fluids for Hemorrhagic Shock.

Rajesh Kumar1, Julia Garcia Mancebo1, Ryan Patenaude1

  • 1Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.

Advanced Materials (Deerfield Beach, Fla.)
|September 25, 2022
PubMed
Summary

A novel zwitterionic polymer offers a safer alternative to traditional colloids for treating hypovolemic shock. This biocompatible volume expander shows improved efficacy and reduced side effects, enhancing fluid resuscitation strategies.

Keywords:
biocompatibilitybiomaterialshemorrhagic shockresuscitationzwitterionic polymers

More Related Videos

Standardized Hemorrhagic Shock Induction Guided by Cerebral Oximetry and Extended Hemodynamic Monitoring in Pigs
07:51

Standardized Hemorrhagic Shock Induction Guided by Cerebral Oximetry and Extended Hemodynamic Monitoring in Pigs

Published on: May 21, 2019

7.5K
Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

1.1K

Related Experiment Videos

Last Updated: Aug 27, 2025

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
16:31

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Published on: June 6, 2011

25.0K
Standardized Hemorrhagic Shock Induction Guided by Cerebral Oximetry and Extended Hemodynamic Monitoring in Pigs
07:51

Standardized Hemorrhagic Shock Induction Guided by Cerebral Oximetry and Extended Hemodynamic Monitoring in Pigs

Published on: May 21, 2019

7.5K
Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

1.1K

Area of Science:

  • Biomaterials Science
  • Polymer Chemistry
  • Resuscitation Medicine

Background:

  • Colloids are widely used as volume expanders for hypovolemic shock, increasing oncotic pressure and intravascular volume.
  • Concerns exist regarding adverse biological interactions with commonly used synthetic colloids.
  • There is a need for safer and more effective fluid resuscitation agents.

Purpose of the Study:

  • To design and evaluate a novel amine(N)-oxide-based zwitterionic polymer as a biocompatible alternative volume expander.
  • To assess the polymer's antifouling properties, clearance mechanisms, and safety profile.
  • To compare its efficacy in restoring intravascular volume against existing colloids and plasma in a hemorrhagic shock model.

Main Methods:

  • Synthesis and characterization of an N-oxide-based zwitterionic polymer.
  • In vitro assessment of antifouling properties and cell interaction.
  • In vivo studies evaluating biodistribution, clearance (renal filtration, hepatic circulation), hemostasis, and acute safety.
  • Hemorrhagic shock model to compare oncotic potency and volume restoration with conventional fluids.

Main Results:

  • The zwitterionic polymer demonstrated significant antifouling capabilities, preventing cell adhesion and organ deposition.
  • Rapid clearance via renal and hepatic pathways was observed, minimizing long-term risks.
  • In vitro and in vivo studies confirmed an absence of adverse effects on hemostasis and acute safety.
  • The polymer exhibited superior oncotic potency compared to existing colloids and plasma in restoring intravascular volume during hemorrhagic shock.

Conclusions:

  • N-oxide-based zwitterionic polymers represent a promising new class of biomaterials for fluid resuscitation.
  • This novel polymer offers improved biocompatibility, efficacy, and safety for treating hypovolemic shock.
  • The findings suggest potential for developing advanced fluid therapies and improving general fluid management strategies.